Association of Perceived Discrimination With Emotional Well-being in Older Adults With Visual Impairment.


Journal

JAMA ophthalmology
ISSN: 2168-6173
Titre abrégé: JAMA Ophthalmol
Pays: United States
ID NLM: 101589539

Informations de publication

Date de publication:
01 07 2019
Historique:
pubmed: 31 5 2019
medline: 23 2 2020
entrez: 31 5 2019
Statut: ppublish

Résumé

A significant proportion of individuals with visual impairment report experiences of discrimination. However, evidence comparing perceived discrimination among people with visual impairment with the general population is lacking. In addition, poorer mental health and well-being have been detected in this population, but the association between discrimination and well-being in those with visual impairment is unknown. To investigate perceived discrimination among people with visual impairment and its association with well-being in a population-based sample of older adults. This study collected data from 7677 participants 50 years or older from the English Longitudinal Study of Ageing, a representative sample of older men and women in England. Experiences of perceived discrimination were reported from July 2010 to June 2011. Depressive symptoms, life satisfaction, quality of life, and loneliness were assessed from July 2010 to June 2011 and May 2016 to June 2017. Data analysis was performed from September 27, 2018, to October 10, 2018. Self-rated eyesight, categorized as poor (ratings of fair, poor, or blind) or good (good, very good, or excellent), which was not previously validated for this population. We used logistic regression to analyze differences in perceived discrimination between participants reporting poor vs good eyesight and cross-sectional and prospective associations between perceived discrimination and well-being in those with poor eyesight. A total of 7677 participants (mean [SD] age, 66.71 [9.17] years; 4023 [52.4%] female) were included in the study. Participants with poor eyesight had increased odds of reporting perceived discrimination compared with those with good eyesight (odds ratio [OR], 1.41; 95% CI, 1.23-1.63; P < .001). Cross-sectionally, participants who reported poor eyesight and discrimination had increased odds of depressive symptoms (OR, 2.14; 95% CI, 1.57-2.92; P < .001) and loneliness (OR, 2.17; 95% CI, 1.61-2.92; P < .001) and lower quality of life (B = -4.06; 95% CI, -5.29 to -2.84; P < .001) and life satisfaction (B = -2.37; 95% CI, -3.28 to -1.46; P < .001) compared with poor eyesight and no reported discrimination. Prospectively, perceived discrimination was associated with increased risk of depressive symptoms among participants reporting poor eyesight at 6-year follow-up (OR, 1.72; 95% CI, 1.08-2.76; P = .02). These findings suggest that older adults with impaired vision are at increased risk of perceived discrimination. Those who reported experiencing discrimination had higher levels of depressive symptoms and loneliness and lower quality of life and life satisfaction. Action to address discrimination may help mitigate the increased risk of poor well-being in this population.

Identifiants

pubmed: 31145413
pii: 2734217
doi: 10.1001/jamaophthalmol.2019.1230
pmc: PMC6547384
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

825-832

Commentaires et corrections

Type : CommentIn

Références

Am J Public Health. 2003 Feb;93(2):200-8
pubmed: 12554570
Arch Gerontol Geriatr. 2016 Jan-Feb;62:30-5
pubmed: 26553484
Psychol Bull. 2009 Jul;135(4):531-54
pubmed: 19586161
Int J Epidemiol. 2006 Aug;35(4):888-901
pubmed: 16585055
Gerontologist. 2013 Dec;53(6):950-62
pubmed: 23471603
Clin Psychol Rev. 2010 Dec;30(8):1019-29
pubmed: 20708315
J Pers Assess. 1996 Feb;66(1):20-40
pubmed: 8576833
Int J Obes (Lond). 2015 May;39(5):858-64
pubmed: 25327975
Cad Saude Publica. 2013 Mar;29(3):445-59
pubmed: 23532281
J Public Health (Oxf). 2016 Jun;38(2):e21-8
pubmed: 26177816
Int J Geriatr Psychiatry. 1997 Sep;12(9):955-9
pubmed: 9309476
Aging Ment Health. 2003 May;7(3):186-94
pubmed: 12775399
J Aging Health. 2011 Aug;23(5):843-61
pubmed: 21398572
Ophthalmic Epidemiol. 2014 Oct;21(5):287-96
pubmed: 24955821
Int J Epidemiol. 2013 Dec;42(6):1640-8
pubmed: 23143611
Invest Ophthalmol Vis Sci. 2010 Jun;51(6):2891-6
pubmed: 20164466
JAMA. 2003 Jan 1;289(1):76-9
pubmed: 12503980
Psychol Bull. 2003 Sep;129(5):674-697
pubmed: 12956539
Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):5797-801
pubmed: 23530191
J Am Geriatr Soc. 2018 Sep;66(9):1823-1829
pubmed: 30098017
BMJ Open Ophthalmol. 2017 Jan 3;1(1):e000046
pubmed: 29354702
Public Health. 2017 Jan;142:7-14
pubmed: 28057201
Ophthalmology. 2015 Apr;122(4):851-61
pubmed: 25573719
Am J Ophthalmol. 2011 Feb;151(2):195-7.e2
pubmed: 21251493
Invest Ophthalmol Vis Sci. 2015 Jan 20;56(2):849-54
pubmed: 25604690
Age Ageing. 2014 May;43(3):379-86
pubmed: 24077751
J Gerontol B Psychol Sci Soc Sci. 2007 May;62(3):S198-202
pubmed: 17507596
J Pers Assess. 1985 Feb;49(1):71-5
pubmed: 16367493
Arch Intern Med. 2012 Jul 23;172(14):1078-83
pubmed: 22710744
BMC Health Serv Res. 2018 Jan 30;18(1):63
pubmed: 29382329
Am J Prev Med. 2003 Oct;25(3 Suppl 2):164-71
pubmed: 14552941
Br J Ophthalmol. 2012 May;96(5):614-8
pubmed: 22133988
Ophthalmology. 2007 Feb;114(2):283-8
pubmed: 17270678
Int J Epidemiol. 1989 Jun;18(2):451-6
pubmed: 2767862
Sci Rep. 2018 Feb 1;8(1):2083
pubmed: 29391510
Arch Ophthalmol. 2012 Aug;130(8):1028-37
pubmed: 22893074
Invest Ophthalmol Vis Sci. 2004 Jan;45(1):71-6
pubmed: 14691156

Auteurs

Sarah E Jackson (SE)

Department of Behavioural Science and Health, University College London, London, United Kingdom.

Ruth A Hackett (RA)

Department of Behavioural Science and Health, University College London, London, United Kingdom.

Shahina Pardhan (S)

Vision and Eye Research Unit, School of Medicine, Anglia Ruskin University, Cambridge, United Kingdom.

Lee Smith (L)

Cambridge Centre for Sport and Exercise Sciences, Anglia Ruskin University, Cambridge, United Kingdom.

Andrew Steptoe (A)

Department of Behavioural Science and Health, University College London, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH